Paul A Gilbert1, Noel T Brewer, Paul L Reiter. 1. Department of Health Behavior and Health Education, UNC Gillings School of Global Public Health, Chapel Hill, NC 27599-7440, USA. paul.gilbert@unc.edu
Abstract
OBJECTIVE: Anal cancer and other diseases caused by human papillomavirus (HPV) are more common among people who are HIV-positive. To understand the potential role of HIV status in HPV prevention efforts, we examined HPV-related knowledge, attitudes, and beliefs among HIV-positive and HIV-negative gay men. MATERIALS AND METHODS: In January 2009, we interviewed a national sample of 247 adult gay men from the United States that included an oversample of HIV-positive men. RESULTS: Status of HIV was not associated with most beliefs about HPV-related diseases (i.e., genital warts, oral cancer, and anal cancer); however, HIV-positive men had higher worry about and perceived likelihood of these diseases. Most men correctly believed that HIV increases risk of HPV-related diseases, yet 29% to 42% still did not. Relatively few men believed that HPV vaccine works in males or that physicians are allowed to give it to men. Acceptability of the HPV vaccine was high and not associated with HIV status (78% of HIV-positive men vs 74% of HIV-negative men; adjusted odds ratio = 1.48; 95% confidence interval = 0.67-3.27). CONCLUSIONS: The high acceptability of HPV vaccine, relatively low knowledge of how HIV increases risk for HPV-related diseases, and misperceptions about HPV vaccine can inform HPV prevention efforts for gay men. The few differences by HIV status suggest that HPV prevention programs may be able to use similar approaches with both HIV-negative and HIV-positive gay men.
OBJECTIVE:Anal cancer and other diseases caused by human papillomavirus (HPV) are more common among people who are HIV-positive. To understand the potential role of HIV status in HPV prevention efforts, we examined HPV-related knowledge, attitudes, and beliefs among HIV-positive and HIV-negative gay men. MATERIALS AND METHODS: In January 2009, we interviewed a national sample of 247 adult gay men from the United States that included an oversample of HIV-positive men. RESULTS: Status of HIV was not associated with most beliefs about HPV-related diseases (i.e., genital warts, oral cancer, and anal cancer); however, HIV-positive men had higher worry about and perceived likelihood of these diseases. Most men correctly believed that HIV increases risk of HPV-related diseases, yet 29% to 42% still did not. Relatively few men believed that HPV vaccine works in males or that physicians are allowed to give it to men. Acceptability of the HPV vaccine was high and not associated with HIV status (78% of HIV-positive men vs 74% of HIV-negative men; adjusted odds ratio = 1.48; 95% confidence interval = 0.67-3.27). CONCLUSIONS: The high acceptability of HPV vaccine, relatively low knowledge of how HIV increases risk for HPV-related diseases, and misperceptions about HPV vaccine can inform HPV prevention efforts for gay men. The few differences by HIV status suggest that HPV prevention programs may be able to use similar approaches with both HIV-negative and HIV-positive gay men.
Authors: Peter V Chin-Hong; Eric Vittinghoff; Ross D Cranston; Lynette Browne; Susan Buchbinder; Grant Colfax; Maria Da Costa; Teresa Darragh; Dana Jones Benet; Franklyn Judson; Beryl Koblin; Kenneth H Mayer; Joel M Palefsky Journal: J Natl Cancer Inst Date: 2005-06-15 Impact factor: 13.506
Authors: Alexandra de Pokomandy; Danielle Rouleau; George Ghattas; Sylvie Vézina; Pierre Coté; John Macleod; Guy Allaire; Eduardo L Franco; François Coutlée Journal: J Infect Dis Date: 2009-04-01 Impact factor: 5.226
Authors: Annie-Laurie McRee; Noel T Brewer; Paul L Reiter; Sami L Gottlieb; Jennifer S Smith Journal: Sex Transm Dis Date: 2010-04 Impact factor: 2.830
Authors: Vivian Colón-López; Lizbeth M Del Toro-Mejías; Ana P Ortiz; Guillermo Tortolero-Luna; Joel M Palefsky Journal: P R Health Sci J Date: 2012-12 Impact factor: 0.705
Authors: Daniel Grace; Mark Gaspar; Rachelle Paquette; Ron Rosenes; Ann N Burchell; Troy Grennan; Irving E Salit Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240
Authors: Andreia B Alexander; Nathan W Stupiansky; Mary A Ott; Debby Herbenick; Michael Reece; Gregory D Zimet Journal: BMC Pediatr Date: 2012-12-14 Impact factor: 2.125
Authors: Daniel Grace; Mark Gaspar; Ron Rosenes; Ramandip Grewal; Ann N Burchell; Troy Grennan; Irving E Salit Journal: Int J Equity Health Date: 2019-10-17